mounjaro (tirzepatide) 5mg
Condition : New
0
From UAE
To Germany
in 5-10 days
Description
How it Works
Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. Tirzepatide works by activating GIP and GLP-1 receptors, which play roles in the regulation of insulin and glucagon secretion. By stimulating these receptors, tirzepatide enhances insulin secretion in response to meals, suppresses glucagon release, slows gastric emptying, and promotes satiety. These combined actions help improve blood glucose control and aid in weight management for individuals with type 2 diabetes.Side Effects
- Nausea
- Diarrhea
- Vomiting
- Decreased appetite
- Abdominal pain
- Constipation
- Injection site reactions (e.g., redness, itching)
- Headache
- Hypoglycemia (especially when used with other diabetes medications)
- Pancreatitis
Indications
- Type 2 diabetes mellitus in adults to improve glycemic control as an adjunct to diet and exercise
Contraindications
- Hypersensitivity to tirzepatide or any of its components
- History of medullary thyroid carcinoma
- Multiple endocrine neoplasia syndrome type 2
- Severe gastrointestinal disease (e.g., gastroparesis)
- Pregnancy and lactation (use with caution)
Price Comparison in Different Countries
Country | Price (USD) | Website |
---|---|---|
United States | $975 | GoodRx |
Canada | $900 | PharmacyChecker |
United Kingdom | ?800 | NHS |
Australia | AUD 1,500 | PBS |
India | ?70,000 | Medindia |
Pakistan | PKR 160,000 | Dawaai |
Top 5 Global Brands
- Mounjaro (Eli Lilly)
- Trulicity (Eli Lilly, GLP-1 receptor agonist)
- Ozempic (Novo Nordisk, GLP-1 receptor agonist)
- Victoza (Novo Nordisk, GLP-1 receptor agonist)
- Bydureon (AstraZeneca, GLP-1 receptor agonist)